Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-308-9 | CAS number: 13291-61-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restriction (limited documentation)
- Justification for type of information:
- The substance trisodium hydrogen ethylenediaminetetraacetate (CAS 150-38-9) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- uninduced and arochlor induced liver S9 mix of male Fischer 344 rats, B6C3F1 mice, and Syrian hamsters
- Test concentrations with justification for top dose:
- 10; 33; 100; 333; 1000; 3333; 10000 µg/plate
- Vehicle / solvent:
- distilled water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: - S9 mix: 2-Nitrofluorene; n-Methyl-N`-nitro-N-nitrosoguanidine; +S9: 2-aminoanthracene; 2-2(furyl)-3-(5-nitro-2-furyl)acrylamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar
NUMBER OF REPLICATIONS: 3 - Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/ cell type: S. typhimurium TA 1535
- Conclusions:
- Interpretation of results (migrated information):
negative - Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restriction (limited documentation)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- GLP compliance:
- no
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- uninduced and arochlor induced liver S9 mix of male Fischer 344 rats, B6C3F1 mice, and Syrian hamsters
- Test concentrations with justification for top dose:
- 10; 33; 100; 333; 1000; 3333; 10000 µg/plate
- Vehicle / solvent:
- distilled water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: - S9 mix: 2-Nitrofluorene; n-Methyl-N`-nitro-N-nitrosoguanidine; +S9: 2-aminoanthracene; 2-2(furyl)-3-(5-nitro-2-furyl)acrylamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar
NUMBER OF REPLICATIONS: 3 - Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/ cell type: S. typhimurium TA 1535
- Conclusions:
- Interpretation of results (migrated information):
negative - Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study without detailed documentation
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- no
- Type of assay:
- other: mammalian cell gene mutation assay
- Specific details on test material used for the study:
- Purity of the test item was 100%. Stock solutions were prepared before use.
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague-Dawley rat liver S9
- Test concentrations with justification for top dose:
- 250, 500, 1000, 1500, 2000 µg/ml
- Vehicle / solvent:
- Water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: for test without metabolic activation: ethyl methane sulfonate (EMS); for test with metabolic activation: 3-methylcholanthrene (MCA)
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 2000 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- There were no increases in the number of small colonies, and the proportion of large and small colonies remained constant for all compounds.
- Conclusions:
- Interpretation of results (migrated information):
negative - Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study without detailed documentation
- Justification for type of information:
- The substance Ethylenediaminetetraacetic acid disodium salt dihydrate (CAS 139-33-3) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- no
- Type of assay:
- other: mammalian cell gene mutation assay
- Specific details on test material used for the study:
- Purity of the test item was 100%. Stock solutions were prepared before use.
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague-Dawley rat liver S9
- Test concentrations with justification for top dose:
- 250, 500, 1000, 1500, 2000 µg/ml
- Vehicle / solvent:
- Water
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: for test without metabolic activation: ethyl methane sulfonate (EMS); for test with metabolic activation: 3-methylcholanthrene (MCA)
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 2000 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- There were no increases in the number of small colonies, and the proportion of large and small colonies remained constant for all compounds.
- Conclusions:
- Interpretation of results (migrated information):
negative - Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- BALB/c-3T3 transformation assay was evaluated because chemical-induced morphologically transformed cells are easily recognized and induced at relatively high frequencies in this assay.
BALB/c-3T3 transformation assay: BALB/c-3T3 cells were grown in soft agar. Non-malignant cells grow at low frequencies in soft agar, transformed cells readily grew in soft agar and were tumorigenic in vivo. - GLP compliance:
- no
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- Supplied by Radian.
- Species / strain / cell type:
- other: BALB/c-3T3
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- First Experiment: 250; 361; 500; 750 µg/ml (0.907; 1.36; 1.81; 2.72 mM)
Second Experiment: 231; 461; 643; 770 µg/ml (0.837; 1.67; 2.33; 2.79 mM) - Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Details on test system and experimental conditions:
- Each transformation assay contained: a standard clonal survival assay, a co-culture clonal survival assay, a transformation assay. In each experiment, chemical-induced transformation was detected in 18-20 vessels/dose seeded with 3.2 x 10E4 cells/vessel. Chemical doses were applied to cell cultures for 48 hr, days 2-4, using standard procedures. The chemical was tested at four treatment doses in two independent trials.
- Evaluation criteria:
- The number of type I-III transformed foci of BALB/c-3T3 cells were identified microscopically using published criteria, and type III foci had three phenotypic properties: piling and overlapping cells, disorientation of cells at the periphery of the focus, and invasion of transformed cells into a contact-inhibited monolayer of WT cells. Type I and II foci also appeared in many different sizes, but they lacked one or more of the three phenotypic properties of the type III transformed focus.
- Statistics:
- rank t-statistics
- Key result
- Species / strain:
- other: BALB/c-3T3
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Na3EDTA was moderately cytotoxic to the BALB/c-3T3 cells and had an average LD50 of 1.89 mM. The statistical sensitivities of transformation assay trials 1 and 2 were 80 and 67/110, respectively; the detection sensitivities for BaP of trials 1 and 2 were 89 and 78/110, respectively. The test chemical had a limited activity transformation response in the first experiment, and a sufficient negative response in the second experiment. Ethylenediamine tetraacetic acid, trisodium salt, was evaluated as inactive in the transformation assay, and its actual and estimated rank t-statistics were 1.41 and 2.01, respectively.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- The substance Trisodium hydrogen ethylenediaminetetraacetate (CAS 150-38-9) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- BALB/c-3T3 transformation assay was evaluated because chemical-induced morphologically transformed cells are easily recognized and induced at relatively high frequencies in this assay.
BALB/c-3T3 transformation assay: BALB/c-3T3 cells were grown in soft agar. Non-malignant cells grow at low frequencies in soft agar, transformed cells readily grew in soft agar and were tumorigenic in vivo. - GLP compliance:
- no
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- Supplied by Radian.
- Species / strain / cell type:
- other: BALB/c-3T3
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- First Experiment: 250; 361; 500; 750 µg/ml (0.907; 1.36; 1.81; 2.72 mM)
Second Experiment: 231; 461; 643; 770 µg/ml (0.837; 1.67; 2.33; 2.79 mM) - Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Details on test system and experimental conditions:
- Each transformation assay contained: a standard clonal survival assay, a co-culture clonal survival assay, a transformation assay. In each experiment, chemical-induced transformation was detected in 18-20 vessels/dose seeded with 3.2 x 10E4 cells/vessel. Chemical doses were applied to cell cultures for 48 hr, days 2-4, using standard procedures. The chemical was tested at four treatment doses in two independent trials.
- Evaluation criteria:
- The number of type I-III transformed foci of BALB/c-3T3 cells were identified microscopically using published criteria, and type III foci had three phenotypic properties: piling and overlapping cells, disorientation of cells at the periphery of the focus, and invasion of transformed cells into a contact-inhibited monolayer of WT cells. Type I and II foci also appeared in many different sizes, but they lacked one or more of the three phenotypic properties of the type III transformed focus.
- Statistics:
- rank t-statistics
- Key result
- Species / strain:
- other: BALB/c-3T3
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Na3EDTA was moderately cytotoxic to the BALB/c-3T3 cells and had an average LD50 of 1.89 mM. The statistical sensitivities of transformation assay trials 1 and 2 were 80 and 67/110, respectively; the detection sensitivities for BaP of trials 1 and 2 were 89 and 78/110, respectively. The test chemical had a limited activity transformation response in the first experiment, and a sufficient negative response in the second experiment. Ethylenediamine tetraacetic acid, trisodium salt, was evaluated as inactive in the transformation assay, and its actual and estimated rank t-statistics were 1.41 and 2.01, respectively.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Principles of method if other than guideline:
- NTP-Standard Protocol
- GLP compliance:
- no
- Type of assay:
- other: Chromosomal aberration Assay
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague Dawley rat liver S9 enzymes and cofactor mix
- Test concentrations with justification for top dose:
- 50; 75; 100 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- The substance Trisodium hydrogen ethylenediaminetetraacetate (CAS 150-38-9) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Principles of method if other than guideline:
- NTP-Standard Protocol
- GLP compliance:
- no
- Type of assay:
- other: Chromosomal aberration Assay
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced male Sprague Dawley rat liver S9 enzymes and cofactor mix
- Test concentrations with justification for top dose:
- 50; 75; 100 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Principles of method if other than guideline:
- NTP-Standard Protocol
- GLP compliance:
- no
- Type of assay:
- other: Mouse lymphoma Assay
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix from livers of either Aroclor 1254-induced or non-induced male Fischer 344 rats
- Test concentrations with justification for top dose:
- 3000, 4000, 5000 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: - S9 mix: methyl methanesulfonate; + S9 mix: methylcholanthrene
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Justification for type of information:
- The substance Trisodium hydrogen ethylenediaminetetraacetate (CAS 150-38-9) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Principles of method if other than guideline:
- NTP-Standard Protocol
- GLP compliance:
- no
- Type of assay:
- other: Mouse lymphoma Assay
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 Mix from livers of either Aroclor 1254-induced or non-induced male Fischer 344 rats
- Test concentrations with justification for top dose:
- 3000, 4000, 5000 µg/ml
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: - S9 mix: methyl methanesulfonate; + S9 mix: methylcholanthrene
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Endpoint:
- in vitro transformation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Principles of method if other than guideline:
- A cell transformation assay was performed at pH 6.7 using Syrian hamster embryo cells.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
- Species / strain / cell type:
- mammalian cell line, other: Syrian hamster embryo (SHE)
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 24 h exposure: 25; 50; 75; 100 µg/mL
7-day exposure: 25; 50; 75; 100; 125; 150 µg/mL - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Details on test system and experimental conditions:
- DURATION
Upon treatment of the cultures with test chemical, they were either refed with control medium after a 24-h exposure and then left undisturbed for the 7-day clonal expression period or exposed to chemical for the entire 7-day clonal expression period.
NUMBER OF REPLICATIONS:2
- Statistics:
- one-tailed Fisher's Exact
- Key result
- Species / strain:
- mammalian cell line, other: Syrian hamster embryo (SHE)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- After a 24-h exposure, EDTA (in culture medium) was tested at concentrations up to 100 µg/mL (49% RPE) and failed to induce a statistically significant
increase in MTF compared with controls. After a 7-day exposure, EDTA was tested at concentrations up to 150 µg/mL (14% RPE) and failed to induce a
statistically significant increase in transformation frequency compared with controls (see table 1) - Endpoint:
- in vitro transformation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Justification for type of information:
- The substance Disodium dihydrogen ethylenediaminetetraacetate (CAS 139-33-3) is structurally similar to the substance trans-cyclohexane-1,2-dinitrilotetraacetic acid (CAS 13291-61-7), therefore used for the read-across.
- Reason / purpose for cross-reference:
- read-across source
- Principles of method if other than guideline:
- A cell transformation assay was performed at pH 6.7 using Syrian hamster embryo cells.
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell transformation assay
- Species / strain / cell type:
- mammalian cell line, other: Syrian hamster embryo (SHE)
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- 24 h exposure: 25; 50; 75; 100 µg/mL
7-day exposure: 25; 50; 75; 100; 125; 150 µg/mL - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Details on test system and experimental conditions:
- DURATION
Upon treatment of the cultures with test chemical, they were either refed with control medium after a 24-h exposure and then left undisturbed for the 7-day clonal expression period or exposed to chemical for the entire 7-day clonal expression period.
NUMBER OF REPLICATIONS:2
- Statistics:
- one-tailed Fisher's Exact
- Key result
- Species / strain:
- mammalian cell line, other: Syrian hamster embryo (SHE)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- After a 24-h exposure, EDTA (in culture medium) was tested at concentrations up to 100 µg/mL (49% RPE) and failed to induce a statistically significant
increase in MTF compared with controls. After a 7-day exposure, EDTA was tested at concentrations up to 150 µg/mL (14% RPE) and failed to induce a
statistically significant increase in transformation frequency compared with controls (see table 1)
Referenceopen allclose all
Mutagenicity and Cytotoxicity of Na2EDTA with and without metabolic activation
Concentration (ug/ml) | S9 | Relative growth (% of control) | Mutant frequency per 10e6 survivors |
0 | - | 100.0 | 24 |
250 | - | 95.5 | 27 |
500 | - | 79.5 | 27 |
1000 | - | 87.0 | 20 |
1500 | - | 83.5 | 30 |
2000 | - | 65.5 | 29 |
0.25 ug/ml EMS | - | 42.0 | 693 |
0 | + | 100.0 | 48 |
250 | + | 78.5 | 55 |
500 | + | 89.5 | 56 |
1000 | + | 80.5 | 47 |
1500 | + | 107.0 | 40 |
2000 | + | 87.5 | 42 |
5.0 ug/ml MCA | + | 22.0 | 542 |
Mutagenicity and Cytotoxicity of Na2EDTA with and without metabolic activation
Concentration (ug/ml) | S9 | Relative growth (% of control) | Mutant frequency per 10e6 survivors |
0 | - | 100.0 | 24 |
250 | - | 95.5 | 27 |
500 | - | 79.5 | 27 |
1000 | - | 87.0 | 20 |
1500 | - | 83.5 | 30 |
2000 | - | 65.5 | 29 |
0.25 ug/ml EMS | - | 42.0 | 693 |
0 | + | 100.0 | 48 |
250 | + | 78.5 | 55 |
500 | + | 89.5 | 56 |
1000 | + | 80.5 | 47 |
1500 | + | 107.0 | 40 |
2000 | + | 87.5 | 42 |
5.0 ug/ml MCA | + | 22.0 | 542 |
Table 1: Results of the Chromosome Aberrations Test for Na3EDTA. | |||||||||||||||
Study Result: Negative | |||||||||||||||
Activation | Trial | Trial Call | |||||||||||||
No Activation | 1 | Negative | |||||||||||||
Induced Rat Liver S9 | 2 | Negative | |||||||||||||
Trial #:1 Activation: No Activation Date: 10/17/1984 Harvest Time: 13.5 hrs Trial Call: Negative | |||||||||||||||
Dose | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs. | ||||||||||
µg/mL | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | |||
Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | ||||
Cell | Abs. | Cell | Abs. | Cell | Abs. | Cell | Abs. | ||||||||
Abs: Aberrations | |||||||||||||||
Vehicle Control: | Dimethylsulfoxide | 10 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 |
Positive Control: | Mitomycin C | 0.25 | 100 | 29 | 0.29 | 26 | 24 | 0.24 | 22 | 5 | 0.05 | 5 | 0 | 0 | 0 |
1 | 50 | 31 | 0.62 | 46 | 24 | 0.48 | 44 | 7 | 0.14 | 14 | 0 | 0 | 0 | ||
Test Chemical: | Ethylenediamine tetraacetate, trisodium salt (EDTA) | 25 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 |
50 | 100 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | 0 | 0 | 0 | ||
75 | 100 | 5 | 0.05 | 5 | 3 | 0.03 | 3 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
100 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 | ||
Trend: | 1.106 | 1.331 | 0.333 | ||||||||||||
Probability: | 0.134 | 0.092 | 0.37 | ||||||||||||
Trial #:2 Activation: Induced Rat Liver S9 Date: 10/31/1984 Harvest Time: 14.0 hrs Trial Call: Negative | |||||||||||||||
Dose | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs. | ||||||||||
µg/mL | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | |||
Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | ||||
Cell | Abs. | Cell | Abs. | Cell | Abs. | Cell | Abs. | ||||||||
Abs: Aberrations | |||||||||||||||
Positive Control: | Cyclophosphamide | 15 | 100 | 55 | 0.55 | 40 | 29 | 0.29 | 22 | 26 | 0.26 | 22 | 0 | 0 | 0 |
Vehicle Control: | Dimethylsulfoxide | 10 | 100 | 3 | 0.03 | 3 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 0 | 0 | 0 |
Test Chemical: | Ethylenediamine tetraacetate, trisodium salt (EDTA) | 25 | 100 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | 100 | 4 | 0.04 | 4 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | ||
75 | 100 | 4 | 0.04 | 4 | 2 | 0.02 | 2 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
100 | 100 | 3 | 0.03 | 3 | 1 | 0.01 | 1 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
Trend: | 0.686 | -0.156 | 1.164 | ||||||||||||
Probability: | 0.247 | 0.562 | 0.122 | ||||||||||||
Table 1: Results of the Chromosome Aberrations Test for Na3EDTA. | |||||||||||||||
Study Result: Negative | |||||||||||||||
Activation | Trial | Trial Call | |||||||||||||
No Activation | 1 | Negative | |||||||||||||
Induced Rat Liver S9 | 2 | Negative | |||||||||||||
Trial #:1 Activation: No Activation Date: 10/17/1984 Harvest Time: 13.5 hrs Trial Call: Negative | |||||||||||||||
Dose | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs. | ||||||||||
µg/mL | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | |||
Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | ||||
Cell | Abs. | Cell | Abs. | Cell | Abs. | Cell | Abs. | ||||||||
Abs: Aberrations | |||||||||||||||
Vehicle Control: | Dimethylsulfoxide | 10 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 |
Positive Control: | Mitomycin C | 0.25 | 100 | 29 | 0.29 | 26 | 24 | 0.24 | 22 | 5 | 0.05 | 5 | 0 | 0 | 0 |
1 | 50 | 31 | 0.62 | 46 | 24 | 0.48 | 44 | 7 | 0.14 | 14 | 0 | 0 | 0 | ||
Test Chemical: | Ethylenediamine tetraacetate, trisodium salt (EDTA) | 25 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 |
50 | 100 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | 0 | 0 | 0 | ||
75 | 100 | 5 | 0.05 | 5 | 3 | 0.03 | 3 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
100 | 100 | 1 | 0.01 | 1 | 0 | 0 | 0 | 1 | 0.01 | 1 | 0 | 0 | 0 | ||
Trend: | 1.106 | 1.331 | 0.333 | ||||||||||||
Probability: | 0.134 | 0.092 | 0.37 | ||||||||||||
Trial #:2 Activation: Induced Rat Liver S9 Date: 10/31/1984 Harvest Time: 14.0 hrs Trial Call: Negative | |||||||||||||||
Dose | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs. | ||||||||||
µg/mL | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | No. of | Abs | % Cells | |||
Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | Abs. | Per | With | ||||
Cell | Abs. | Cell | Abs. | Cell | Abs. | Cell | Abs. | ||||||||
Abs: Aberrations | |||||||||||||||
Positive Control: | Cyclophosphamide | 15 | 100 | 55 | 0.55 | 40 | 29 | 0.29 | 22 | 26 | 0.26 | 22 | 0 | 0 | 0 |
Vehicle Control: | Dimethylsulfoxide | 10 | 100 | 3 | 0.03 | 3 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 0 | 0 | 0 |
Test Chemical: | Ethylenediamine tetraacetate, trisodium salt (EDTA) | 25 | 100 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | 100 | 4 | 0.04 | 4 | 2 | 0.02 | 2 | 1 | 0.01 | 1 | 1 | 0.01 | 1 | ||
75 | 100 | 4 | 0.04 | 4 | 2 | 0.02 | 2 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
100 | 100 | 3 | 0.03 | 3 | 1 | 0.01 | 1 | 2 | 0.02 | 2 | 0 | 0 | 0 | ||
Trend: | 0.686 | -0.156 | 1.164 | ||||||||||||
Probability: | 0.247 | 0.562 | 0.122 | ||||||||||||
Tables: Results of the mouse lymphoma test with Na3EDTA
Nonactivation Trial: 1 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | H2O | 0 | 64 | 87 | 113 | 59 | 69 |
63 | 112 | 132 | 70 | ||||
65 | 108 | 133 | 68 | ||||
64# | 92 | 148.5 | 78 | ||||
Test Chemical: | 60 | 65 | 107 | 177 | 91 | 83 | |
74 | 109 | 165 | 74 | ||||
70 | 58 | 110 | 97 | 56 | 68 | ||
67 | 113 | 162 | 81 | ||||
80 | 67 | 100 | 131 | 65 | 59 | ||
63# | 116 | 99 | 52 | ||||
90 | 58 | 86 | 119 | 69 | 72 | ||
63 | 93 | 140 | 75 | ||||
100 | 71 | 111 | 142 | 67 | 73 | ||
66 | 101 | 159 | 80 | ||||
Positive Control: | MMS | 15 | 49 | 42 | 293 | 198 | 181* |
53 | 45 | 261 | 164 | ||||
Trial Notes: | |||||||
Nonactivation Trial: 2 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 78 | 103 | 24 | 10 | 18 |
93 | 91 | 50 | 18 | ||||
103 | 104 | 57 | 18 | ||||
84 | 102 | 63 | 25 | ||||
Test Chemical: | 1000 | 80 | 42 | 61 | 25 | 23 | |
76 | 51 | 45 | 20 | ||||
2000 | 87 | 53 | 52 | 20 | 21 | ||
88 | 52 | 61 | 23 | ||||
3000 | 79 | 38 | 47 | 20 | 21 | ||
77 | 50 | 50 | 22 | ||||
4000 | 93 | 32 | 80 | 29 | 27 | ||
65 | 30 | 49 | 25 | ||||
5000 | 79 | 23 | 49 | 21 | 22 | ||
76 | 29 | 54 | 24 | ||||
Positive Control: | MMS | 15 | 52 | 25 | 146 | 93 | 93* |
38 | 18 | 107 | 93 | ||||
Trial Notes: | |||||||
Nonactivation Trial: 3 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 69 | 94 | 88 | 43 | 38 |
62 | 109 | 48 | 26 | ||||
58 | 87 | 79 | 46 | ||||
76 | 110 | 84 | 37 | ||||
Test Chemical: | 1000 | 61 | 59 | 95 | 52 | 57 | |
55 | 60 | 101 | 61 | ||||
2000 | 68 | 73 | 111 | 55 | 49 | ||
61 | 61 | 77 | 42 | ||||
3000 | 62 | 64 | 110 | 59 | 60 | ||
52 | 50 | 95 | 61 | ||||
4000 | 61 | 45 | 74 | 40 | 42 | ||
61 | 51 | 81 | 45 | ||||
5000 | 50 | 34 | 68 | 45 | 46 | ||
55 | 37 | 77 | 47 | ||||
Positive Control: | MMS | 15 | 23 | 24 | 163 | 235 | 217* |
26 | 23 | 156 | 200 | ||||
EMS | 250 | 41 | 61 | 427 | 347 | 325* | |
52 | 59 | 474 | 302 | ||||
Trial Notes: | |||||||
Induced S9 Trial: 1 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 108 | 93 | 101 | 31 | 36 |
102 | 109 | 98 | 32 | ||||
109 | 101 | 119 | 36 | ||||
97 | 97 | 130 | 45 | ||||
Test Chemical: | 1000 | 105 | 74 | 137 | 43 | 47 | |
100 | 78 | 152 | 51 | ||||
2000 | 82 | 58 | 101 | 41 | 42 | ||
97 | 67 | 126 | 43 | ||||
3000 | 99 | 56 | 159 | 54 | 44 | ||
109 | 62 | 113 | 35 | ||||
4000 | 99 | 55 | 106 | 36 | 38 | ||
85 | 45 | 101 | 40 | ||||
5000 | 77 | 36 | 124 | 54 | 55 | ||
85 | 36 | 145 | 57 | ||||
Positive Control: | MCA | 2.5 | 72 | 44 | 615 | 286 | 305* |
70 | 40 | 680 | 323 | ||||
Trial Notes: | |||||||
Induced S9 Trial: 2 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 60 | 96 | 36 | 20 | 20 |
64 | 110 | 35 | 18 | ||||
56 | 92 | 48 | 29 | ||||
66 | 103 | 25 | 13 | ||||
Test Chemical: | 1000 | 52 | 61 | 41 | 26 | 21 | |
63 | 75 | 31 | 16 | ||||
2000 | 67 | 63 | 56 | 28 | 27 | ||
62 | 61 | 48 | 26 | ||||
3000 | 61 | 40 | 41 | 22 | 31 | ||
71 | 48 | 85 | 40 | ||||
4000 | 66 | 41 | 56 | 28 | 29 | ||
57 | 35 | 51 | 30 | ||||
5000 | 70 | 34 | 65 | 31 | 28 | ||
59 | 36 | 45 | 25 | ||||
Positive Control: | MCA | 2.5 | 34 | 19 | 231 | 229 | 232* |
34 | 17 | 237 | 236 | ||||
Trial Notes: | |||||||
Footnotes: | |||||||
Asterisks(*) indicate significant responses. | |||||||
r = rejected value due to quality control criteria | |||||||
# = reduced sample size because of the loss of one culture dish due to contamination | |||||||
MMS = methyl methanesulfonate | |||||||
MCA = methylcholanthrene | |||||||
DMSO = dimethylsulfoxide (solvent) |
Tables: Results of the mouse lymphoma test with Na3EDTA
Nonactivation Trial: 1 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | H2O | 0 | 64 | 87 | 113 | 59 | 69 |
63 | 112 | 132 | 70 | ||||
65 | 108 | 133 | 68 | ||||
64# | 92 | 148.5 | 78 | ||||
Test Chemical: | 60 | 65 | 107 | 177 | 91 | 83 | |
74 | 109 | 165 | 74 | ||||
70 | 58 | 110 | 97 | 56 | 68 | ||
67 | 113 | 162 | 81 | ||||
80 | 67 | 100 | 131 | 65 | 59 | ||
63# | 116 | 99 | 52 | ||||
90 | 58 | 86 | 119 | 69 | 72 | ||
63 | 93 | 140 | 75 | ||||
100 | 71 | 111 | 142 | 67 | 73 | ||
66 | 101 | 159 | 80 | ||||
Positive Control: | MMS | 15 | 49 | 42 | 293 | 198 | 181* |
53 | 45 | 261 | 164 | ||||
Trial Notes: | |||||||
Nonactivation Trial: 2 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 78 | 103 | 24 | 10 | 18 |
93 | 91 | 50 | 18 | ||||
103 | 104 | 57 | 18 | ||||
84 | 102 | 63 | 25 | ||||
Test Chemical: | 1000 | 80 | 42 | 61 | 25 | 23 | |
76 | 51 | 45 | 20 | ||||
2000 | 87 | 53 | 52 | 20 | 21 | ||
88 | 52 | 61 | 23 | ||||
3000 | 79 | 38 | 47 | 20 | 21 | ||
77 | 50 | 50 | 22 | ||||
4000 | 93 | 32 | 80 | 29 | 27 | ||
65 | 30 | 49 | 25 | ||||
5000 | 79 | 23 | 49 | 21 | 22 | ||
76 | 29 | 54 | 24 | ||||
Positive Control: | MMS | 15 | 52 | 25 | 146 | 93 | 93* |
38 | 18 | 107 | 93 | ||||
Trial Notes: | |||||||
Nonactivation Trial: 3 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 69 | 94 | 88 | 43 | 38 |
62 | 109 | 48 | 26 | ||||
58 | 87 | 79 | 46 | ||||
76 | 110 | 84 | 37 | ||||
Test Chemical: | 1000 | 61 | 59 | 95 | 52 | 57 | |
55 | 60 | 101 | 61 | ||||
2000 | 68 | 73 | 111 | 55 | 49 | ||
61 | 61 | 77 | 42 | ||||
3000 | 62 | 64 | 110 | 59 | 60 | ||
52 | 50 | 95 | 61 | ||||
4000 | 61 | 45 | 74 | 40 | 42 | ||
61 | 51 | 81 | 45 | ||||
5000 | 50 | 34 | 68 | 45 | 46 | ||
55 | 37 | 77 | 47 | ||||
Positive Control: | MMS | 15 | 23 | 24 | 163 | 235 | 217* |
26 | 23 | 156 | 200 | ||||
EMS | 250 | 41 | 61 | 427 | 347 | 325* | |
52 | 59 | 474 | 302 | ||||
Trial Notes: | |||||||
Induced S9 Trial: 1 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 108 | 93 | 101 | 31 | 36 |
102 | 109 | 98 | 32 | ||||
109 | 101 | 119 | 36 | ||||
97 | 97 | 130 | 45 | ||||
Test Chemical: | 1000 | 105 | 74 | 137 | 43 | 47 | |
100 | 78 | 152 | 51 | ||||
2000 | 82 | 58 | 101 | 41 | 42 | ||
97 | 67 | 126 | 43 | ||||
3000 | 99 | 56 | 159 | 54 | 44 | ||
109 | 62 | 113 | 35 | ||||
4000 | 99 | 55 | 106 | 36 | 38 | ||
85 | 45 | 101 | 40 | ||||
5000 | 77 | 36 | 124 | 54 | 55 | ||
85 | 36 | 145 | 57 | ||||
Positive Control: | MCA | 2.5 | 72 | 44 | 615 | 286 | 305* |
70 | 40 | 680 | 323 | ||||
Trial Notes: | |||||||
Induced S9 Trial: 2 Experiment Call: Negative and Non-Toxic | |||||||
Conc. | Cloning | Relative Total | Mutant Colonies | Mutant Frequency | AVG Mutant Frequency | ||
µg/mL | Efficiency | Growth | |||||
Vehicle Control: | FOP | 0 | 60 | 96 | 36 | 20 | 20 |
64 | 110 | 35 | 18 | ||||
56 | 92 | 48 | 29 | ||||
66 | 103 | 25 | 13 | ||||
Test Chemical: | 1000 | 52 | 61 | 41 | 26 | 21 | |
63 | 75 | 31 | 16 | ||||
2000 | 67 | 63 | 56 | 28 | 27 | ||
62 | 61 | 48 | 26 | ||||
3000 | 61 | 40 | 41 | 22 | 31 | ||
71 | 48 | 85 | 40 | ||||
4000 | 66 | 41 | 56 | 28 | 29 | ||
57 | 35 | 51 | 30 | ||||
5000 | 70 | 34 | 65 | 31 | 28 | ||
59 | 36 | 45 | 25 | ||||
Positive Control: | MCA | 2.5 | 34 | 19 | 231 | 229 | 232* |
34 | 17 | 237 | 236 | ||||
Trial Notes: | |||||||
Footnotes: | |||||||
Asterisks(*) indicate significant responses. | |||||||
r = rejected value due to quality control criteria | |||||||
# = reduced sample size because of the loss of one culture dish due to contamination | |||||||
MMS = methyl methanesulfonate | |||||||
MCA = methylcholanthrene | |||||||
DMSO = dimethylsulfoxide (solvent) |
Table 1: Results of the cell transformation assay:
RPE (%) | Number of MT/ Total Colonies | MTF (%) | ||
7-day | Control | 100 | 3/1269 | 0.24 |
50 µg/mL | 95 | 2/1187 | 0.17 | |
75 µg/mL | 88 | 0/736 | 0.00 | |
100 µg/mL | 75 | 0/932 | 0.00 | |
125 µg/mL | 51 | 1/424 | 0.24 | |
150 µg/mL | 14 | 0/180 | 0.00 | |
24 h | Control | 100 | 7/1293 | 0.54 |
25 µg/mL | 102 | 7/1317 | 0.53 | |
50 µg/mL | 94 | 13/1182 | 1.10 | |
75 µg/mL | 77 | 4/995 | 0.40 | |
100 µg/mL | 49 | 10/1225 | 0.82 |
RPE = relative plating efficiency; MT = morphologically transformed colonies; MTF = morphological transformation frequency
Table 1: Results of the cell transformation assay:
RPE (%) | Number of MT/ Total Colonies | MTF (%) | ||
7-day | Control | 100 | 3/1269 | 0.24 |
50 µg/mL | 95 | 2/1187 | 0.17 | |
75 µg/mL | 88 | 0/736 | 0.00 | |
100 µg/mL | 75 | 0/932 | 0.00 | |
125 µg/mL | 51 | 1/424 | 0.24 | |
150 µg/mL | 14 | 0/180 | 0.00 | |
24 h | Control | 100 | 7/1293 | 0.54 |
25 µg/mL | 102 | 7/1317 | 0.53 | |
50 µg/mL | 94 | 13/1182 | 1.10 | |
75 µg/mL | 77 | 4/995 | 0.40 | |
100 µg/mL | 49 | 10/1225 | 0.82 |
RPE = relative plating efficiency; MT = morphologically transformed colonies; MTF = morphological transformation frequency
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.